Skip to main navigation Skip to search Skip to main content

A Phase III, Randomised, Double-Blind, Active-Controlled Study to Assess the Efficacy, Safety and Tolerability of Baxdrostat in Combination with Dapagliflozin Compared with Dapagliflozin Alone on Chronic Kidney Disease (CKD) Progression in

Project: Research

Project Details

StatusActive
Effective start/end date04/4/24 → 03/31/27

Funding

  • AstraZeneca Pharmaceuticals LP: $31,130.00